EICHOR
● Active Not Recruiting
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Condition: Overweight , Obesity · Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
About this study
This study will evaluate the percentage change in body weight from baseline and proportion of subjects achieving ≥ 5% weight loss from baseline after 52 weeks of treatment with Zovaglutide in subjects with overweight/obesity.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (45)
| Xuancheng People's Hospital | Xuancheng, Anhui, China | — |
| Beijing Friendship Hospital, Capital Medical University | Beijing, Beijiing, China | — |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| Gansu Provincial Hospital | Lanzhou, Gansu, China | — |
| Guangzhou Red Cross Hospital | Guangzhou, Guangdong, China | — |
| Huizhou Central People's Hospital | Huizhou, Guangdong, China | — |
| The Second Affiliated Hospotal of Guangxi Medical University | Nanning, Guangxi, China | — |
| Handan First Hospital | Handan, Hebei, China | — |
| Hebei Petro China Cental Hospital | Langfang, Hebei, China | — |
| First Hospital of Qinhuangdao | Qinhuangdao, Hebei, China | — |
| The Second Hospital of Hebei Medical University | Shijiangzhuang, Hebei, China | — |
| Harbin Medical University Affiliated Fourth Hospital | Harbin, Heilongjiang, China | — |
+ 33 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07230119